Related Experiment Video
Updated: Apr 11, 2026

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
Vaccinations in paediatric rheumatology: an update on current developments.
Noortje Groot1, Marloes W Heijstek, Nico M Wulffraat
1Department of Pediatrics, Wilhemina Children's Hospital/University Medical Centre Utrecht (UMCU), PO-box 85090, 3508 AB, Utrecht, The Netherlands, n.groot@erasmusmc.nl.
Vaccinations are safe and immunogenic for children with rheumatic diseases. Despite potential waning antibody levels, especially with biologicals, booster vaccinations are recommended to ensure adequate protection.
Area of Science:
- Rheumatology
- Immunology
- Pediatrics
Background:
- European League Against Rheumatism (EULAR) published vaccination recommendations for children with rheumatic diseases in 2011.
- The evidence base on vaccination safety and immunogenicity in this population has significantly expanded since 2011.
Purpose of the Study:
- To provide an updated systematic literature review on the safety and immunogenicity of vaccines in pediatric patients with rheumatic diseases.
- To summarize current evidence and strengthen the existing EULAR recommendations.
Main Methods:
- Conducted a systematic literature search, identifying 21 new articles.
- Included 27 articles from the 2011 review for a comprehensive analysis.
Main Results:
- Vaccines are generally safe and immunogenic in children with rheumatic diseases.
- Immunosuppressive drugs like glucocorticosteroids and methotrexate did not detrimentally affect vaccine immunogenicity.
- Biologicals may lead to faster waning of antibody levels, but initial protection is typically adequate.
Conclusions:
- Reduced persistence of immunological memory in children with rheumatic diseases necessitates booster vaccinations.
- The updated evidence supports advocating for vaccinations in patients with rheumatic diseases.
Related Concept Videos
Vaccinations
Vaccines
Rheumatic Heart Disease III: Medical Management
Microorganisms in Medicine and Therapeutics
Pharmacokinetics in Pediatric Patients: Drug Excretion
Rheumatic Heart Disease IV: Nursing Management

